| Literature DB >> 32375491 |
Heleen Westland1, Marieke J Schuurmans2, Irene D Bos-Touwen1, Marjolein A de Bruin-van Leersum1, Evelyn M Monninkhof1, Carin D Schröder3, Daphne A de Vette1, Jaap Ca Trappenburg1.
Abstract
BACKGROUND: To understand better the success of self-management interventions and to enable tailoring of such interventions at specific subgroups of patients, the nurse-led Activate intervention is developed targeting one component of self-management (physical activity) in a heterogeneous subgroup (patients at risk of cardiovascular disease) in Dutch primary care. AIM: The aim of this study was to evaluate the effectiveness of the Activate intervention and identifying which patient-related characteristics modify the effect.Entities:
Keywords: Behaviour change wheel; cluster-randomised controlled trial; nurse-led intervention; physical activity; primary care; self-management
Mesh:
Year: 2020 PMID: 32375491 PMCID: PMC7817988 DOI: 10.1177/1474515120919547
Source DB: PubMed Journal: Eur J Cardiovasc Nurs ISSN: 1474-5151 Impact factor: 3.908
Figure 1.Study design of the Activate cluster-randomised controlled trial.
Baseline characteristics of participants of the Activate trial.
| Control ( | Intervention ( | |
|---|---|---|
| Female, n (%) | 35 (34.3) | 41 (44.1) |
| Age in years, mean ± SD | 63.4 ± 8.3 | 61.9 ± 9.1 |
| Employed, | 33 (32.4) | 34 (36.6) |
| Living with others, | 87 (85.3) | 76 (81.7) |
| Level of education, | ||
| Primary education or below | 6 (5.9) | 3 (3.3) |
| Secondary education | 69 (68.3) | 67 (72.8) |
| Higher education | 26 (25.7) | 22 (23.9) |
| Smoking, | 11 (10.8) | 14 (15.1) |
| Body mass index, mean ± SD | 29.7 ± 4.8 | 32.7 ± 5.4 |
| <25, | 15 (14.7) | 3 (3.2) |
| 25–29.99, | 47 (46.1) | 30 (32.3) |
| ≥30, | 40 (39.2) | 60 (64.5) |
| Cardiovascular risk factors, | ||
| Hypertension only | 23 (22.5) | 13 (14.0) |
| Hypercholesterolemia only | 7 (6.9) | 5 (5.4) |
| DM2 only | 4 (3.9) | 3 (3.2) |
| Hypertension and hypercholesterolemia | 20 (19.6) | 25 (26.9) |
| Hypertension and DM2 | 9 (8.8) | 8 (8.6) |
| Hypertension, hypercholesterolemia and DM2 | 25 (24.5) | 32 (34.4) |
| Hypercholesterolemia and DM2 | 11 (10.8) | 4 (4.3) |
| Risk unknown | 3 (2.9) | 3 (3.2) |
| Health literacy (HLS-EU-Q), mean ± SD | 35.2 ± 6.9 | 33.9 ± 7.9 |
| Social support (MSPSS), mean ± SD | 65.5 ± 14.8 | 63.8 ± 13.8 |
| Depression (HADS), mean ± SD | 3.9 ± 3.3 | 5.5 ± 3.6 |
| Patient-provider relationship (CAT) | 4.1 ± 0.8 | 4.1 ± 0.7 |
| Meet Dutch physical activity guideline,[ | 43 (43.0) | 52 (55.9) |
CAT: communication assessment tool; DM2: diabetes mellitus type 2; HADS: hospital anxiety and depression scale; HLS-EU-Q: European health literacy survey questionnaire; MSPSS: multidimensional scale of perceived social support.
aDutch physical activity guideline consists of at least 30 minutes of moderate to vigorous activity on at least 5 days weekly, measured with the accelerometer.
Treatment effect for the primary and secondary outcome measures (intention-to-treat).
| Outcome measure | Control group ( | Intervention group ( | Treatment effect (6 months) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Mean ± SD (linear mixed models) | Unadjusted | Adjusted* | ||||||||
| Baseline | 3 months | 6 months | Baseline | 3 months | 6 months | MD (95% CI) | MD (95% CI) | |||
| Physical activity[ | 38.9 ± 22.6 | 39.8 ± 25.9 | 39.9 ± 26.1 | 37.5 ± 21.1 | 43.3 ± 20.7 | 44.2 ± 24.4 | 2.92 (–6.2; 12.1) | 0.52 | 2.49 (–2.1; 7.1) | 0.28 |
| Physical activity[ | 50.7 ± 33.4 | 52.3 ± 35.4 | 65.4 ± 48.8 | 49.4 ± 29.6 | 56.8 ± 29.7 | 69.4 ± 46.8 | 3.57 (–8.4; 15.5) | 0.55 | 2.41 (–4.3; 9.1) | 0.48 |
| Daily sedentary time[ | 82.6 ± 5.7 | 82.5 ± 5.8 | 82.9 ± 5.9 | 83.3 ± 5.5 | 83.0 ± 5.9 | 83.3 ± 5.3 | 0.54 (–1.5; 2.6) | 0.60 | 0.31(–0.6; 1.9) | 0.50 |
| Exercise Self-efficacy Scale | 51.8 ± 17.7 | 57.7 ± 16.8 | 59.0 ± 16.7 | 49.4 ± 17.1 | 57.0 ± 17.3 | 58.8 ± 16.0 | –0.82 (–5.8; 4.2) | 0.75 | –0.79 (–4.6; 3.0) | 0.68 |
| PAM-13 | 59.2 ± 12.2 | 60.1 ± 14.0 | 61.6 ± 11.9 | 57.2 ± 12.2 | 59.9 ± 12.7 | 59.7 ± 14.0 | –1.59 (–5.4; 2.2) | 0.41 | 0.03 (–2.9; 3.0) | 0.99 |
Mean ± SD (ANCOVA) |
|
| Standardised coefficients (95% CI) | |||||||
| EQ-5D-3L | 0.8 ± 0.2 | NA | 0.8 ± 0.2 | 0.8 ± 0.2 | NA | 0.8 ± 0.2 | 0.02 (0.0; 0.05) | 0.17 | ||
| EQ VAS score | 73.6 ± 14.1 | NA | 75.2 ± 14.6 | 67.3 ± 14.7 | NA | 70.0 ± 12.4 | 0.16 (–3.2; 3.5) | 0.92 | ||
CI: confidence interval; MD: mean difference; NA: not applicable; PAM-13: patient activation measure short form; VAS: visual analogue scale.
aDaily minutes of moderate to vigorous physical activity.
bObjective daily minutes of moderate to vigorous physical activity measured with the accelerometer added with self-reported cycling, swimming, strength training.
cPercentage of the wear time spent in the sedentary category (<1.8 METS).
*Adjusted for baseline measurement.
Figure 2.CONSORT flowchart of general practices and participants assigned to the intervention and control group.
*Data available for at least 4 week days and one weekend day for 8 hours.
Treatment effect for the primary and secondary outcome measures (per protocol).
| Outcome measure | Control group ( | Intervention group ( | Treatment effect (6 months) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Mean ± SD (linear mixed models) | Unadjusted | Adjusted* | ||||||||
| Baseline | 3 months | 6 months | Baseline | 3 months | 6 months | MD (95% CI) | MD (95% CI) | |||
| Physical activity[ | 38.7 ± 22.8 | 39.8 ± 25.9 | 39.1 ± 25.4 | 40.8 ± 21.3 | 43.3 ± 20.7 | 44.7 ± 24.3 | 3.98 (–5.0; 12.9) | 0.52 | 2.55 (–2.0; 7.2) | 0.26 |
| Physical activity[ | 51.6 ± 33.3 | 52.3 ± 35.4 | 65.4 ± 49.2 | 54.1 ± 30.1 | 56.8 ± 29.7 | 70.1 ± 46.8 | 4.00 (–8.0; 16.0) | 0.51 | 2.43 (–4.3; 9.1) | 0.48 |
| Daily sedentary time[ | 82.6 ± 5.8 | 82.5 ± 5.8 | 82.9 ± 5.9 | 82.7 ± 5.5 | 83.0 ± 5.9 | 83.3 ± 5.3 | 0.51 (–1.6; 2.6) | 0.63 | 0.35 (–0.5; 1.2) | 0.44 |
| Exercise self–efficacy Scale | 50.7 ± 17.7 | 57.7 ± 16.8 | 58.5 ± 16.5 | 51.5 ± 17.6 | 57.0 ± 17.3 | 59.0 ± 16.1 | –0.25 (–5.2; 4.7) | 0.92 | –0.71 (–4.6; 3.2) | 0.72 |
| PAM-13 | 59.1 ± 11.7 | 60.6 ± 14.0 | 61.5 ± 12.0 | 57.9 ± 12.4 | 59.9 ± 12.7 | 60.1 ± 13.9 | –1.25 (–5.1; 2.6) | 0.52 | –0.07 (–2.9; 3.1) | 0.96 |
Mean ± SD (ANCOVA) |
|
| Standardised coefficients (95% CI) | |||||||
| EQ-5D-3L | 0.8 ± 0.2 | NA | 0.8 ± 0.2 | 0.8 ± 0.2 | NA | 0.8 ± 0.2 | 0.01 (0.0; 0.04) | 0.46 | ||
| EQ VAS score | 73.9 ± 14.5 | NA | 75.4 ± 14.7 | 67.7 ± 15.3 | NA | 70.0 ± 12.4 | 0.24 (–3.2; 3.6) | 0.89 | ||
CI: confidence interval; MD: mean difference; NA: not applicable; PAM-13: patient activation measure short form; VAS: visual analogue scale.
aDaily minutes of moderate to vigorous physical activity.
bObjective daily minutes of moderate to vigorous physical activity measured with the accelerometer added with self-reported cycling, swimming, strength training.
cPercentage of the wear time spent in the sedentary category (<1.8 METS).
*Adjusted for baseline measurement.
Figure 3.Estimated means of the multidimensional scale of perceived social support.
Figure 4.Estimated means of baseline physical activity.